EWA
ALXO icon

EverSource Wealth Advisors’s ALX Oncology ALXO Stock Holding History

EverSource Wealth Advisors’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.87K Hold
905
– – ﹤0.01% 3747
2026
Q1 		$1.81K Buy
+905
New +$1.72K ﹤0.01% 3679
2025
Q4 		– Sell
-499
Closed -$913 – 4279
2025
Q3 		$913 Sell
499
-130
-21% -$113 ﹤0.01% 3790
2025
Q2 		$261 Buy
629
+99
+19% +$50 ﹤0.01% 4020
2025
Q1 		$330 Buy
+530
New +$636 ﹤0.01% 3578

Other funds holding ALXO

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
JF
JSF Financial Los Angeles, California $632M AUM 27.63% 1-Year Est. Return
AHL
Abel Hall LLC Baton Rouge, Louisiana $579M AUM 54.21% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

EverSource Wealth Advisors's ALXO Position: Q2 2026 in Review

EverSource Wealth Advisors held its ALX Oncology (ALXO) position steady in Q2 2026 at 905 shares worth $1.87K. The position accounts for ﹤0.01% of the portfolio, ranked #3747.

EverSource Wealth Advisors first reported a position in ALXO in Q1 2025 and has held it in 5 quarters since. 10 funds tracked by Wall St. Rank hold ALXO as of Q2 2026.

  • EverSource Wealth Advisors held 905 shares of ALX Oncology worth $1.87K as of Q2 2026.
  • EverSource Wealth Advisors left its ALX Oncology share count unchanged in Q2 2026.
  • ALX Oncology made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3747 holding.
  • EverSource Wealth Advisors first reported a position in ALX Oncology in Q1 2025 and has held it in 5 quarters since.
  • 10 funds tracked by Wall St. Rank held ALX Oncology as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.